301 related articles for article (PubMed ID: 17486138)
1. A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity.
O'Dea EL; Barken D; Peralta RQ; Tran KT; Werner SL; Kearns JD; Levchenko A; Hoffmann A
Mol Syst Biol; 2007; 3():111. PubMed ID: 17486138
[TBL] [Abstract][Full Text] [Related]
2. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.
Hoffmann A; Levchenko A; Scott ML; Baltimore D
Science; 2002 Nov; 298(5596):1241-5. PubMed ID: 12424381
[TBL] [Abstract][Full Text] [Related]
3. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB dictates the degradation pathway of IkappaBalpha.
Mathes E; O'Dea EL; Hoffmann A; Ghosh G
EMBO J; 2008 May; 27(9):1357-67. PubMed ID: 18401342
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.
Tergaonkar V; Correa RG; Ikawa M; Verma IM
Nat Cell Biol; 2005 Sep; 7(9):921-3. PubMed ID: 16136188
[TBL] [Abstract][Full Text] [Related]
7. The role of [beta]-transducin repeat-containing protein ([beta]-TrCP) in the regulation of NF-[kappa]B in vascular smooth muscle cells.
Wang X; Adhikari N; Li Q; Guan Z; Hall JL
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):85-90. PubMed ID: 14592850
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction. Decoding NF-kappaB signaling.
Ting AY; Endy D
Science; 2002 Nov; 298(5596):1189-90. PubMed ID: 12424362
[No Abstract] [Full Text] [Related]
9. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
[TBL] [Abstract][Full Text] [Related]
11. Enhanced heat shock protein 70 expression alters proteasomal degradation of IkappaB kinase in experimental acute respiratory distress syndrome.
Weiss YG; Bromberg Z; Raj N; Raphael J; Goloubinoff P; Ben-Neriah Y; Deutschman CS
Crit Care Med; 2007 Sep; 35(9):2128-38. PubMed ID: 17855826
[TBL] [Abstract][Full Text] [Related]
12. Homogeneous assays for cellular protein degradation using beta-galactosidase complementation: NF-kappaB/IkappaB pathway signaling.
Zhao X; Vainshtein I; Gellibolian R; Shu Y; Dotimas H; Wang XM; Fung P; Horecka J; Bosano BL; Eglen RM
Assay Drug Dev Technol; 2003 Dec; 1(6):823-33. PubMed ID: 15090228
[TBL] [Abstract][Full Text] [Related]
13. IkappaB kinase and NF-kappaB signaling in response to pro-inflammatory cytokines.
Delhase M
Methods Mol Biol; 2003; 225():7-17. PubMed ID: 12769469
[No Abstract] [Full Text] [Related]
14. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
[TBL] [Abstract][Full Text] [Related]
15. IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.
Tergaonkar V; Bottero V; Ikawa M; Li Q; Verma IM
Mol Cell Biol; 2003 Nov; 23(22):8070-83. PubMed ID: 14585967
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.
Fiedler MA; Wernke-Dollries K; Stark JM
Am J Respir Cell Mol Biol; 1998 Aug; 19(2):259-68. PubMed ID: 9698598
[TBL] [Abstract][Full Text] [Related]
17. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F
Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784
[TBL] [Abstract][Full Text] [Related]
18. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
[TBL] [Abstract][Full Text] [Related]
19. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1996 Dec; 15(23):6716-26. PubMed ID: 8978697
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
Karin M; Ben-Neriah Y
Annu Rev Immunol; 2000; 18():621-63. PubMed ID: 10837071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
